ALT FY 2019 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-43.8% YoY

Gross Profit

$6M100.0% margin

Operating Income

-$21M-370.0% margin

Net Income

-$21M-353.7% margin

EPS (Diluted)

$-1.56

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$54M

Total Liabilities

$9M

Stockholders' Equity

$46M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$10M	-43.8%
Gross Profit	$6M	-$8M	+171.4%
Operating Income	-$21M	-$43M	+49.9%
Net Income	-$21M	-$39M	+47.6%